Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
42401
Flow diagram.
Published 2024“…Future studies should include additional assessment points in the first trimester and more than six months postpartum and try to include a matched control group of non-pregnant women to compare prevalence rates and trajectory of body image dissatisfaction.…”
-
42402
The lagged impact of different factors and scenarios on COVID-19 transmission during the Delta wave in 2021.
Published 2025“…<b>(G)</b> – (<b>I</b>) COVID-19 lag-response association for precipitation (Prec) at 0.05, 0.5, and 1m, relative to the overall mean of 0.15m. …”
-
42403
-
42404
-
42405
-
42406
A Novel Potent Anticancer Compound Optimized from a Natural Oridonin Scaffold Induces Apoptosis and Cell Cycle Arrest through the Mitochondrial Pathway
Published 2017“…Furthermore, <b>13p</b> induced apoptosis and cell cycle arrest at the G2/M phase. A decrease in mitochondrial membrane potential and an increase in Bax/Bcl-2 ratio, accompanied by activated caspase-3 cleavage, were observed in MCF-7 cells after treatment with <b>13p</b>, suggesting that the mitochondrial pathway was involved in the <b>13p</b>-mediated apoptosis. …”
-
42407
-
42408
-
42409
-
42410
-
42411
-
42412
-
42413
-
42414
Preparation and NMR Spectra of the (Trifluoromethyl)argentates(III) [Ag(CF<sub>3</sub>)<i><sub>n</sub></i>X<sub>4-<i>n</i></sub><i></i>]<sup>-</sup>, with X = CN (<i>n</i> = 1−3),...
Published 1997“…In the [Ag(CF<sub>3</sub>)<sub>3</sub>(CH<sub>3</sub>)]<sup>-</sup> anion, the Ag−CH<sub>3</sub> distance (2.097(5) Å) is slightly shorter than the average Ag−CF<sub>3</sub> bond lengths (2.119(10) Å).…”
-
42415
Attaining the Utmost Stability and Energy of Carbonyl Azides by the Synergistic Improvement of Conjugation and H-bonding
Published 2024“…In this study, we present a new family of carbonyl azides, 5-nitro-1H-1,2,4-triazol-3-yl-carbamoyl-azide (NTCA), which was synthesized through in situ oxidation cleavage of amino-tetrazole. …”
-
42416
-
42417
Synthetic Control of Excited-State Properties in Cyclometalated Ir(III) Complexes Using Ancillary Ligands
Published 2005“…The Ir−C<sub>aryl</sub> bond lengths in (<i>tpy</i>)<sub>2</sub>Ir(CN-<i>t-</i>Bu)<sub>2</sub><sup>+</sup> (2.047(5) and 2.072(5) Å) and (<i>tpy</i>)<sub>2</sub>Ir(PPh<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>BPh<sub>2</sub> (2.047(9) and 2.057(9) Å) are longer than their counterparts in (<i>tpy</i>)<sub>2</sub>Ir(acac) (1.982(6) and 1.985(7) Å). …”
-
42418
Synthetic Control of Excited-State Properties in Cyclometalated Ir(III) Complexes Using Ancillary Ligands
Published 2005“…The Ir−C<sub>aryl</sub> bond lengths in (<i>tpy</i>)<sub>2</sub>Ir(CN-<i>t-</i>Bu)<sub>2</sub><sup>+</sup> (2.047(5) and 2.072(5) Å) and (<i>tpy</i>)<sub>2</sub>Ir(PPh<sub>2</sub>CH<sub>2</sub>)<sub>2</sub>BPh<sub>2</sub> (2.047(9) and 2.057(9) Å) are longer than their counterparts in (<i>tpy</i>)<sub>2</sub>Ir(acac) (1.982(6) and 1.985(7) Å). …”
-
42419
Quality as a function of coverage, according to theoretical model.
Published 2011“…The solid black curve shows that expected sequence quality increases nearly linearly with expected coverage, at a rate of ∼3.62 <i>phred</i> units per additional 1× of coverage, corresponding to a 10−3.62/lO≈43% decrease in the error rate. …”
-
42420
The difference in outcome parameters between groups.
Published 2017“…<p>Outcome parameters represent the followings; O1, decrease of time-averaged proteinuria from trial phase and to the observational phase; O2, remission of UPCR <0.2 g/g cr during observational phase; O3, rapid decline of eGFR ≥5 mL/min/1.73 m<sup>2</sup> during observational phase; O4, composite outcome of increase in serum cr level (≥50% from baseline) noted during observational phase or deterioration of renal function to end stage renal disease. …”